ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Tucson Conference Could Be Lively

February 16, 1979

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

Breast Cancer Incidence Goes Up, Most of it in Early, Local Stages

July 11, 1988